NCT02850991View on ClinicalTrials.gov

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2022

Conditions
Esophageal Cancer
Interventions
RADIATION

High-dose

Drug: concurrent chemotherapy with radiation paclitaxel plus carboplatin are used weekly in both arms

RADIATION

Standard-dose

Drug: concurrent chemotherapy with radiation paclitaxel plus carboplatin are used weekly in both arms

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER

NCT02850991 - Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma | Biotech Hunter | Biotech Hunter